Literature DB >> 27060942

Does Microglial Activation Influence Hippocampal Volume and Neuronal Function in Alzheimer's Disease and Parkinson's Disease Dementia?

Grazia D Femminella1, Siddharth Ninan1, Rebecca Atkinson1, Zhen Fan1, David J Brooks1,2, Paul Edison1.   

Abstract

BACKGROUND: The influence of neuroinflammation on neuronal function and hippocampal atrophy in Alzheimer's disease (AD) and Parkinson's disease dementia (PDD) is still unclear.
OBJECTIVES: Here we investigated whether microglial activation measured by [11C]PK11195 PET is associated with neuronal function measured by cerebral glucose metabolic rate (rCMRGlc) using FDG-PET and hippocampal volume measurements.
METHODS: We enrolled 25 subjects (9 PDD, 8 AD, and 8 controls) who underwent PET scans with [11C](R)PK11195, [18F]FDG, and volumetric MRI scanning.
RESULTS: SPM correlation analysis in AD and PDD showed a negative correlation between hippocampal volume and microglial activation within hippocampus or parahippocampus and with cortical and subcortical areas of projections from hippocampus, while there was a positive correlation between rCMRGlc in cortical and subcortical areas of projections from hippocampus and hippocampal volume. Hippocampal volume was significantly reduced in AD compared to controls but not in PDD.
CONCLUSIONS: These findings indicate that microglial activation inversely correlated with hippocampal volume and hippocampal rCMRGlc in neurodegenerative diseases with dementia, providing further evidence for the central role of microglial activation in neurodegenerative diseases.

Entities:  

Keywords:  Alzheimer’s disease; PET; Parkinson’s disease with dementia; neuroinflammation; volumetric MRI

Mesh:

Substances:

Year:  2016        PMID: 27060942     DOI: 10.3233/JAD-150827

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  22 in total

Review 1.  Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias.

Authors:  Nicolaas I Bohnen; Martijn L T M Müller; Kirk A Frey
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-14       Impact factor: 5.081

Review 2.  In vivo PET imaging of neuroinflammation in Alzheimer's disease.

Authors:  Julien Lagarde; Marie Sarazin; Michel Bottlaender
Journal:  J Neural Transm (Vienna)       Date:  2017-05-17       Impact factor: 3.575

3.  Brain Volume Changes in Patients with Acute Brain Dysfunction Due to Sepsis.

Authors:  Günseli Orhun; Erdem Tüzün; Başar Bilgiç; Perihan Ergin Özcan; Serra Sencer; Mehmet Barburoğlu; Figen Esen
Journal:  Neurocrit Care       Date:  2020-04       Impact factor: 3.210

Review 4.  Microglia Biomarkers in Alzheimer's Disease.

Authors:  Peng-Fei Zhang; Hao Hu; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2021-03-12       Impact factor: 5.590

Review 5.  Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?

Authors:  Fangda Leng; Paul Edison
Journal:  Nat Rev Neurol       Date:  2020-12-14       Impact factor: 42.937

Review 6.  Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.

Authors:  Chiara Cerami; Leonardo Iaccarino; Daniela Perani
Journal:  Int J Mol Sci       Date:  2017-05-05       Impact factor: 5.923

Review 7.  Translocator Protein-18 kDa (TSPO) Positron Emission Tomography (PET) Imaging and Its Clinical Impact in Neurodegenerative Diseases.

Authors:  Anne-Claire Dupont; Bérenger Largeau; Maria Joao Santiago Ribeiro; Denis Guilloteau; Claire Tronel; Nicolas Arlicot
Journal:  Int J Mol Sci       Date:  2017-04-07       Impact factor: 5.923

8.  Microglial activation and tau burden predict cognitive decline in Alzheimer's disease.

Authors:  Maura Malpetti; Rogier A Kievit; Luca Passamonti; P Simon Jones; Kamen A Tsvetanov; Timothy Rittman; Elijah Mak; Nicolas Nicastro; W Richard Bevan-Jones; Li Su; Young T Hong; Tim D Fryer; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

Review 9.  In vivo Imaging of Glial Activation in Alzheimer's Disease.

Authors:  Paul Edison; Cornelius K Donat; Magdalena Sastre
Journal:  Front Neurol       Date:  2018-08-07       Impact factor: 4.003

10.  Application of advanced brain positron emission tomography-based molecular imaging for a biological framework in neurodegenerative proteinopathies.

Authors:  Daniela Perani; Leonardo Iaccarino; Andreas H Jacobs
Journal:  Alzheimers Dement (Amst)       Date:  2019-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.